14 November 2018

Extra funding for strategic move into downstream formulation and fill-finish capabilities and full exploitation of Lock-Release as new ADC manufacturing paradigm

READ PRESS RELEASE

26 April 2018

Conjugation Process Improvements – Application of Lock Release Technology – Poster presented at the Protein Engineering Summit (Boston)

READ PRESS RELEASE

29 March 2018

ADCBIO presented at World ADC Conference on their conjugation process technologies

READ PRESS RELEASE

25 April 2018

ADC Biotechnology has successfully secured a £1.14m investment from Downing LLP to finance innovative bioconjugation and their US expansion plans

READ PRESS RELEASE

4 February 2018

ADC BIO announces the development of a revolutionary, ‘downstream bio-conjugation’ method that will present a new paradigm in Antibody Drug Conjugate (ADC) development and manufacturing.

READ PRESS RELEASE

5 December 2017

ADC BIO has signed a partnership agreement with multi-disciplined engineering specialists, WHP.

READ PRESS RELEASE

14 November 2017

Experts at ADC Bio warn of impending problems in the ADC pipeline with millions wasted in development costs.

READ PRESS RELEASE

25 September 2017

ADC BIO has secured investment for the construction of an $11 million bioconjugation facility at its new site in Deeside, North Wales, UK.

READ PRESS RELEASE